In this context, IL-17A has been found to promote tumor cell growth and proliferation, angiogenesis via production of vascular endothelial growth factor (VEGF) by tumor cells, as well as invasion and metastasis via production of matrix metalloproteinase-9 by tumor cells and other cell types (119, 121, 122). Here, MMP9 is linked to neoplasm.